Cell-in-cell structure mediates in-cell killing suppressed by CD44.


Journal

Cell discovery
ISSN: 2056-5968
Titre abrégé: Cell Discov
Pays: England
ID NLM: 101661034

Informations de publication

Date de publication:
19 Apr 2022
Historique:
received: 18 07 2021
accepted: 28 01 2022
entrez: 19 4 2022
pubmed: 20 4 2022
medline: 20 4 2022
Statut: epublish

Résumé

Penetration of immune cells into tumor cells was believed to be immune-suppressive via cell-in-cell (CIC) mediated death of the internalized immune cells. We unexpectedly found that CIC formation largely led to the death of the host tumor cells, but not the internalized immune cells, manifesting typical features of death executed by NK cells; we named this "in-cell killing" which displays the efficacy superior to the canonical way of "kiss-killing" from outside. By profiling isogenic cells, CD44 on tumor cells was identified as a negative regulator of "in-cell killing" via inhibiting CIC formation. CD44 functions to antagonize NK cell internalization by reducing N-cadherin-mediated intercellular adhesion and by enhancing Rho GTPase-regulated cellular stiffness as well. Remarkably, antibody-mediated blockade of CD44 signaling potentiated the suppressive effects of NK cells on tumor growth associated with increased heterotypic CIC formation. Together, we identified CIC-mediated "in-cell killing" as a promising strategy for cancer immunotherapy.

Identifiants

pubmed: 35436988
doi: 10.1038/s41421-022-00387-1
pii: 10.1038/s41421-022-00387-1
pmc: PMC9016064
doi:

Types de publication

Journal Article

Langues

eng

Pagination

35

Subventions

Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 31970685
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 81872314

Informations de copyright

© 2022. The Author(s).

Références

Fais, S. & Overholtzer, M. Cell-in-cell phenomena in cancer. Nat. Rev. Cancer 18, 758–766 (2018).
doi: 10.1038/s41568-018-0073-9 pubmed: 30420767
Huang, H., Chen, Z. & Sun, Q. Mammalian cell competitions, cell-in-cell phenomena and their biomedical implications. Curr. Mol. Med. 15, 852–860 (2015).
doi: 10.2174/1566524015666151026101101 pubmed: 26511708
Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486–541 (2018).
doi: 10.1038/s41418-017-0012-4 pubmed: 29362479 pmcid: 5864239
Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131, 966–979 (2007).
doi: 10.1016/j.cell.2007.10.040 pubmed: 18045538
Wang, S. et al. Rapid reuptake of granzyme B leads to emperitosis: an apoptotic cell-in-cell death of immune killer cells inside tumor cells. Cell Death Dis. 4, e856 (2013).
doi: 10.1038/cddis.2013.352 pubmed: 24113190 pmcid: 3824662
Lugini, L. et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res 66, 3629–3638 (2006).
doi: 10.1158/0008-5472.CAN-05-3204 pubmed: 16585188
Huang, H. et al. Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple staining. Oncotarget 6, 20278–20287 (2015).
doi: 10.18632/oncotarget.4275 pubmed: 26109430 pmcid: 4653004
Huang, H. et al. Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma. Signal Transduct. Target Ther. 5, 246–248 (2020).
doi: 10.1038/s41392-020-00346-w pubmed: 33082315 pmcid: 7576137
Zhang, X. et al. Subtype-based prognostic analysis of cell-in-cell structures in early breast cancer. Front Oncol. 9, 1–12 (2019).
pubmed: 30761267 pmcid: 6361832
Fan, J. et al. Role of heterotypic neutrophil-in-tumor structure in the prognosis of patients with buccal mucosa squamous cell carcinoma. Front. Oncol. 10, 541878 (2020).
doi: 10.3389/fonc.2020.541878 pubmed: 33178577 pmcid: 7593655
Wang, Y. et al. Subtype-based analysis of cell-in-cell structures in esophageal squamous cell carcinoma. Front. Oncol. 11, 670051 (2021).
doi: 10.3389/fonc.2021.670051 pubmed: 34178655 pmcid: 8231019
Sun, Q. et al. Competition between human cells by entosis. Cell Res. 24, 1299–1310 (2014).
doi: 10.1038/cr.2014.138 pubmed: 25342560 pmcid: 4220161
Kroemer, G. & Perfettini, J.-L. Entosis, a key player in cancer cell competition. Cell Res. 24, 1280–1281 (2014).
doi: 10.1038/cr.2014.133 pubmed: 25342563 pmcid: 4220158
Sun, Q., Cibas, E. S., Huang, H., Hodgson, L. & Overholtzer, M. Induction of entosis by epithelial cadherin expression. Cell Res. 24, 1288–1298 (2014).
doi: 10.1038/cr.2014.137 pubmed: 25342558 pmcid: 4220160
Wang, M. et al. Mechanical ring interfaces between adherens junction and contractile actomyosin to coordinate entotic cell-in-cell formation. Cell Rep. 32, 108071 (2020).
doi: 10.1016/j.celrep.2020.108071 pubmed: 32846129
Mackay, H. L. et al. Genomic instability in mutant p53 cancer cells upon entotic engulfment. Nat. Commun. 9, 3070 (2018).
doi: 10.1038/s41467-018-05368-1 pubmed: 30076358 pmcid: 6076230
Liang, J. et al. CDKN2A inhibits formation of homotypic cell-in-cell structures. Oncogenesis 7, 1–8 (2018).
doi: 10.1038/s41389-018-0056-4
Niu, Z., He, M. & Sun, Q. Molecular mechanisms underlying cell-in-cell formation: core machineries and beyond. J. Mol. Cell Biol. 13, 329–334 (2021).
doi: 10.1093/jmcb/mjab015 pubmed: 33693765 pmcid: 8373266
Rizzotto, D. & Villunger, A. P53 clears aneuploid cells by entosis. Cell Death Differ. 28, 818–820 (2021).
doi: 10.1038/s41418-020-00659-x pubmed: 33149274
Wang, Y. & Wang, X.-N. Cell-in-cell: a virgin land of cell biology. Oncoimmunology 2, e25988 (2013).
doi: 10.4161/onci.25988 pubmed: 24244895 pmcid: 3825734
Fais, S. Cannibalism: a way to feed on metastatic tumors. Cancer Lett. 258, 155–164 (2007).
doi: 10.1016/j.canlet.2007.09.014 pubmed: 17977647
Salvesen, G. S. Dying from within: granzyme B converts entosis to emperitosis. Cell Death Differ. 21, 3–4 (2014).
doi: 10.1038/cdd.2013.157 pubmed: 24317271
Wang, X. Cell-in-cell phenomenon: a new paradigm in life sciences. Curr. Mol. Med. 15, 810–818 (2015).
doi: 10.2174/1566524015666151026095730 pubmed: 26511712 pmcid: 5403960
Sun, Q. & Chen, W. Cell-in-cell: an Emerging Player in COVID-19 and Immune Disorders. Natl. Sci. Open https://doi.org/10.1051/nso/2021004 (2022).
Ponta, H., Sherman, L. & Herrlich, P. A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4, 33–45 (2003).
doi: 10.1038/nrm1004 pubmed: 12511867
Coleman, M. L. et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339–345 (2001).
doi: 10.1038/35070009 pubmed: 11283606
Wang, S. et al. Internalization of NK cells into tumor cells requires ezrin and leads to programmed cell-in-cell death. Cell Res. 19, 1350–1362 (2009).
doi: 10.1038/cr.2009.114 pubmed: 19786985
Miao, C., Schiffhauer, E. S., Okeke, E. I., Robinson, D. N. & Luo, T. Parallel compression is a fast low-cost assay for the high-throughput screening of mechanosensory cytoskeletal proteins in cells. ACS Appl. Mater. Interfaces 9, 28168–28179 (2017).
doi: 10.1021/acsami.7b04622 pubmed: 28795554 pmcid: 5891216
Wang, Z., Zhao, K., Hackert, T. & Zöller, M. CD44/CD44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression. Front. Cell Dev. Biol. 6, 97 (2018).
doi: 10.3389/fcell.2018.00097 pubmed: 30211160 pmcid: 6122270
Lisi, S., Sisto, M., Lofrumento, D. D., D’Amore, S. & D’Amore, M. Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake. Clin. Exp. Med. 11, 1–10 (2011).
doi: 10.1007/s10238-010-0098-1 pubmed: 20454994
Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98–w102 (2017).
doi: 10.1093/nar/gkx247 pubmed: 28407145 pmcid: 5570223
Nagy, Á., Lánczky, A., Menyhárt, O. & Győrffy, B. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci. Rep. 8, 9227 (2018).
doi: 10.1038/s41598-018-27521-y pubmed: 29907753 pmcid: 6003936
Su, Y. et al. Role and dynamics of vacuolar pH during cell-in-cell mediated death. Cell Death Dis. 12, 119 (2021).
doi: 10.1038/s41419-021-03396-2 pubmed: 33483474 pmcid: 7822940
Liang, J. et al. p53-dependent elimination of aneuploid mitotic offspring by entosis. Cell Death Differ. 28, 799–813 (2021).
doi: 10.1038/s41418-020-00645-3 pubmed: 33110215
Krajcovic, M., Krishna, S., Akkari, L., Joyce, J. A. & Overholtzer, M. mTOR regulates phagosome and entotic vacuole fission. Mol. Biol. Cell 24, 3736–3745 (2013).
doi: 10.1091/mbc.e13-07-0408 pubmed: 24088573 pmcid: 3842999
Krajcovic, M. et al. A non-genetic route to aneuploidy in human cancers. Nat. Cell Biol. 13, 324–330 (2011).
doi: 10.1038/ncb2174 pubmed: 21336303 pmcid: 3576821
Benseler, V. et al. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc. Natl. Acad. Sci. USA 108, 16735–16740 (2011).
doi: 10.1073/pnas.1112251108 pubmed: 21933957 pmcid: 3189041
Zhang, Z. et al. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ. 28, 2765–2777 (2021).
doi: 10.1038/s41418-021-00782-3 pubmed: 33879858 pmcid: 8056997
Lin, L., Li, Q., Wang, Y. & Shi, Y. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Differ. 28, 1–3 (2021).
doi: 10.1038/s41418-021-00795-y
Chao, K.-C., Yang, H.-T. & Chen, M.-W. Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell–cell contact and internalization. J. Cell. Mol. Med. 16, 1803–1815 (2012).
doi: 10.1111/j.1582-4934.2011.01459.x pubmed: 21973190 pmcid: 3822693
Bartosh, T. J., Ullah, M., Zeitouni, S., Beaver, J. & Prockop, D. J. Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs). Proc. Natl Acad. Sci. USA 113, E6447–E6456 (2016).
doi: 10.1073/pnas.1612290113 pubmed: 27698134 pmcid: 5081643
Brown, G. C. & Neher, J. J. Microglial phagocytosis of live neurons. Nat. Rev. Neurosci. 15, 209–216 (2014).
doi: 10.1038/nrn3710 pubmed: 24646669
Davies, S. P. et al. Hepatocytes delete regulatory T cells by enclysis, a CD4(+) T cell engulfment process. Cell Rep. 29, 1610–1620 (2019).
doi: 10.1016/j.celrep.2019.09.068 pubmed: 31693899 pmcid: 7057271
Salama, R., Girgis, G. & Zhou, J. Erythrophagocytosis by neutrophils associated with Clostridium perfringens-induced hemolytic anemia. Ann. Hematol. 94, 521–522 (2015).
doi: 10.1007/s00277-014-2184-z pubmed: 25109599
Chen, Y.-h et al. Prevalence of heterotypic tumor/immune cell-in-cell structure in vitro and in vivo leading to formation of aneuploidy. PLoS One 8, e59418 (2013).
doi: 10.1371/journal.pone.0059418 pubmed: 23555668 pmcid: 3610684
Tang, M. et al. AIM-CICs: automatic identification method for Cell-in-cell structures based on convolutional neural network. bioRxiv, https://doi.org/10.1101/2021.02.26.432996 (2022).
Wang, C. et al. PCDH7 inhibits the formation of homotypic cell-in-cell structure. Front. Cell Dev. Biol. 8, 329 (2020).
doi: 10.3389/fcell.2020.00329 pubmed: 32457908 pmcid: 7225324
Ruan, B. et al. Expression profiling identified IL-8 as a regulator of homotypic cell-in-cell formation. BMB Rep. 51, 412–417 (2018).
doi: 10.5483/BMBRep.2018.51.8.089 pubmed: 30021676 pmcid: 6130832
Ning, X., Luo, T., Chen, Z. & Sun, Q. The physics for the formation of cell-in-cell structures. Cur. Mol. Med. 15, 867–872 (2015).
doi: 10.2174/1566524015666151026105123
Srinivasan, A., Chang, S. Y., Zhang, S., Toh, W. S. & Toh, Y. C. Substrate stiffness modulates the multipotency of human neural crest derived ectomesenchymal stem cells via CD44 mediated PDGFR signaling. Biomaterials 167, 153–167 (2018).
doi: 10.1016/j.biomaterials.2018.03.022 pubmed: 29571051
Zheng, Y., Zhou, L., Su, Y. & Sun, Q. Cell fusion in the pathogenesis of COVID-19. Mil. Med. Res. 8, 68 (2021).
pubmed: 34924024 pmcid: 8684830
Fang, F., Xiao, W. & Tian, Z. NK cell-based immunotherapy for cancer. Semin. Immunol. 31, 37–54 (2017).
doi: 10.1016/j.smim.2017.07.009 pubmed: 28838796
Shimasaki, N., Jain, A. & Campana, D. NK cells for cancer immunotherapy. Nat. Rev. Drug Discov. 19, 200–218 (2020).
doi: 10.1038/s41573-019-0052-1 pubmed: 31907401
Wang, W., Jiang, J. & Wu, C. CAR-NK for tumor immunotherapy: clinical transformation and future prospects. Cancer Lett. 472, 175–180 (2020).
doi: 10.1016/j.canlet.2019.11.033 pubmed: 31790761
Vacca, P. et al. Exploiting human NK cells in tumor therapy. Front. Immunol. 10, 3013 (2019).
doi: 10.3389/fimmu.2019.03013 pubmed: 32010130
Varun, B. R., Jayanthi, P. & Ramani, P. Cancer stem cells: a comprehensive review on identification and therapeutic implications. Journal of oral and maxillofacial pathology. J. Oral. Maxillofac. Pathol. 24, 190 (2020).
doi: 10.4103/jomfp.JOMFP_336_19 pubmed: 32508482 pmcid: 7269290
Philp, D. et al. The binding, internalization, and release of thymocytes by thymic nurse cells. Cell Immunol. 148, 301–315 (1993).
doi: 10.1006/cimm.1993.1114 pubmed: 8495496
Jiang, X. et al. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity. Signal Transduct. Target Ther. 5, 268–271 (2020).
doi: 10.1038/s41392-020-00392-4 pubmed: 33203835 pmcid: 7670837
Ren, H. et al. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection. Biol. Direct 16, 20 (2021).
doi: 10.1186/s13062-021-00305-7 pubmed: 34674770 pmcid: 8530504
Niu, Z. et al. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal Transduct. Target Ther. 6, 284 (2021).
doi: 10.1038/s41392-021-00704-2 pubmed: 34315847 pmcid: 8313414
Zhou, L. et al. Senescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer. Cell Death Disco. 8, 13 (2022).
doi: 10.1038/s41420-021-00769-6

Auteurs

Yan Su (Y)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.
CAS Key Laboratory of Mechanical Behavior and Design of Materials, Department of Modern Mechanics, University of Science and Technology of China, Hefei, China.

Hongyan Huang (H)

Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China.

Tianzhi Luo (T)

CAS Key Laboratory of Mechanical Behavior and Design of Materials, Department of Modern Mechanics, University of Science and Technology of China, Hefei, China.

You Zheng (Y)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Jie Fan (J)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

He Ren (H)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.
Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China.

Meng Tang (M)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.
Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China.

Zubiao Niu (Z)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Chenxi Wang (C)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Yuqi Wang (Y)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Zhengrong Zhang (Z)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Jianqing Liang (J)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Banzhan Ruan (B)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Lihua Gao (L)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Zhaolie Chen (Z)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.

Gerry Melino (G)

Departments of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
DZNE German Center for Neurodegenerative Diseases, Bonn, Germany.

Xiaoning Wang (X)

National Research Center of Geriatrics Diseases, Chinese PLA General Hospital, Beijing, China.
School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.

Qiang Sun (Q)

Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China. sunq@bmi.ac.cn.

Classifications MeSH